These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

670 related items for PubMed ID: 21865691

  • 1. Aberrant glycosylation of IgA1 and anti-glycan antibodies in IgA nephropathy: role of mucosal immune system.
    Novak J, Moldoveanu Z, Julian BA, Raska M, Wyatt RJ, Suzuki Y, Tomino Y, Gharavi AG, Mestecky J, Suzuki H.
    Adv Otorhinolaryngol; 2011; 72():60-3. PubMed ID: 21865691
    [Abstract] [Full Text] [Related]

  • 2. The pathogenic role of IgA1 O-linked glycosylation in the pathogenesis of IgA nephropathy.
    Barratt J, Smith AC, Feehally J.
    Nephrology (Carlton); 2007 Jun; 12(3):275-84. PubMed ID: 17498123
    [Abstract] [Full Text] [Related]

  • 3. Recognition of galactose-deficient O-glycans in the hinge region of IgA1 by N-acetylgalactosamine-specific snail lectins: a comparative binding study.
    Gomes MM, Suzuki H, Brooks MT, Tomana M, Moldoveanu Z, Mestecky J, Julian BA, Novak J, Herr AB.
    Biochemistry; 2010 Jul 13; 49(27):5671-82. PubMed ID: 20507092
    [Abstract] [Full Text] [Related]

  • 4. IgA nephropathy and Henoch-Schoenlein purpura nephritis: aberrant glycosylation of IgA1, formation of IgA1-containing immune complexes, and activation of mesangial cells.
    Novak J, Moldoveanu Z, Renfrow MB, Yanagihara T, Suzuki H, Raska M, Hall S, Brown R, Huang WQ, Goepfert A, Kilian M, Poulsen K, Tomana M, Wyatt RJ, Julian BA, Mestecky J.
    Contrib Nephrol; 2007 Jul 13; 157():134-8. PubMed ID: 17495451
    [Abstract] [Full Text] [Related]

  • 5. O-glycosylation of serum IgA1 antibodies against mucosal and systemic antigens in IgA nephropathy.
    Smith AC, Molyneux K, Feehally J, Barratt J.
    J Am Soc Nephrol; 2006 Dec 13; 17(12):3520-8. PubMed ID: 17093066
    [Abstract] [Full Text] [Related]

  • 6. Structural features of IgA molecules which contribute to IgA nephropathy.
    Feehally J, Allen AC.
    J Nephrol; 1999 Dec 13; 12(2):59-65. PubMed ID: 10378660
    [Abstract] [Full Text] [Related]

  • 7. Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy.
    Moura IC, Arcos-Fajardo M, Gdoura A, Leroy V, Sadaka C, Mahlaoui N, Lepelletier Y, Vrtovsnik F, Haddad E, Benhamou M, Monteiro RC.
    J Am Soc Nephrol; 2005 Sep 13; 16(9):2667-76. PubMed ID: 15987753
    [Abstract] [Full Text] [Related]

  • 8. Integrin α1/β1 and α2/β1 as a receptor for IgA1 in human glomerular mesangial cells in IgA nephropathy.
    Kaneko Y, Otsuka T, Tsuchida Y, Gejyo F, Narita I.
    Int Immunol; 2012 Apr 13; 24(4):219-32. PubMed ID: 22298882
    [Abstract] [Full Text] [Related]

  • 9. IgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy.
    Novak J, Julian BA, Tomana M, Mestecky J.
    Semin Nephrol; 2008 Jan 13; 28(1):78-87. PubMed ID: 18222349
    [Abstract] [Full Text] [Related]

  • 10. Genetics and immunopathogenesis of IgA nephropathy.
    Yu HH, Chu KH, Yang YH, Lee JH, Wang LC, Lin YT, Chiang BL.
    Clin Rev Allergy Immunol; 2011 Oct 13; 41(2):198-213. PubMed ID: 21188648
    [Abstract] [Full Text] [Related]

  • 11. Pathogenic role of glycan-specific IgG antibodies in IgA nephropathy.
    Zhao YF, Zhu L, Liu LJ, Shi SF, Lv JC, Zhang H.
    BMC Nephrol; 2017 Sep 29; 18(1):301. PubMed ID: 28969604
    [Abstract] [Full Text] [Related]

  • 12. Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells.
    Wang Y, Zhao MH, Zhang YK, Li XM, Wang HY.
    Clin Exp Immunol; 2004 Apr 29; 136(1):168-75. PubMed ID: 15030528
    [Abstract] [Full Text] [Related]

  • 13. Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies.
    Tomana M, Novak J, Julian BA, Matousovic K, Konecny K, Mestecky J.
    J Clin Invest; 1999 Jul 29; 104(1):73-81. PubMed ID: 10393701
    [Abstract] [Full Text] [Related]

  • 14. Pathogenesis of IgA nephropathy.
    Feehally J, Allen AC.
    Ann Med Interne (Paris); 1999 Feb 29; 150(2):91-8. PubMed ID: 10392257
    [Abstract] [Full Text] [Related]

  • 15. New insights in the pathogenesis of IgA nephropathy.
    Monteiro RC.
    Nefrologia; 2005 Feb 29; 25 Suppl 2():82-6. PubMed ID: 16050408
    [Abstract] [Full Text] [Related]

  • 16. Immunopathogenesis of IgAN.
    Barratt J, Smith AC, Molyneux K, Feehally J.
    Semin Immunopathol; 2007 Nov 29; 29(4):427-43. PubMed ID: 17851660
    [Abstract] [Full Text] [Related]

  • 17. IgA nephropathy and aberrant glycosylation of tonsillar, serum and glomerular IgA1.
    Hiki Y, Ito A, Yamamoto Y, Yamamoto K, Iwase H.
    Adv Otorhinolaryngol; 2011 Nov 29; 72():68-70. PubMed ID: 21865693
    [Abstract] [Full Text] [Related]

  • 18. Cellular signaling and production of galactose-deficient IgA1 in IgA nephropathy, an autoimmune disease.
    Reily C, Ueda H, Huang ZQ, Mestecky J, Julian BA, Willey CD, Novak J.
    J Immunol Res; 2014 Nov 29; 2014():197548. PubMed ID: 25152896
    [Abstract] [Full Text] [Related]

  • 19. Glycosylation of IgA1 and pathogenesis of IgA nephropathy.
    Novak J, Julian BA, Mestecky J, Renfrow MB.
    Semin Immunopathol; 2012 May 29; 34(3):365-82. PubMed ID: 22434325
    [Abstract] [Full Text] [Related]

  • 20. Aberrant Glycosylation of the IgA1 Molecule in IgA Nephropathy.
    Novak J, Barratt J, Julian BA, Renfrow MB.
    Semin Nephrol; 2018 Sep 29; 38(5):461-476. PubMed ID: 30177018
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.